Home› The Breastcancer.org Community Forum› In treatment› Targeted Therapy - Before, During, and After

FDA Approves Dato-DXd for advanced-stage HR+, HER2- breast cancer

moderators
moderators Posts: 10,640
February 2025 in Targeted Therapy - Before, During, and After

https://www.breastcancer.org/treatment/targeted-therapy/dato-dxd
Tagged:
  • Metastatic Breast Cancer (MBC or Stage IV)
  • ER-positive
  • HER2-negative
  • Hormone receptor-positive HER2-negative
  • PR-positive
  • Dato-DXd (Datroway)
0

Comments

  • threetree
    threetree Posts: 2,834
    February 2025

    Just read about this online. Looks like it has some real nasty side effects, so no improvement in that department.

    1

Categories

  • All Categories
  • 1.6K Concerned about my risk
  • 1.9K Connect with others like me
  • 2.2K In treatment
  • 642 Managing life with cancer
  • 169 Finished treatment
  • 863 Living with metastatic disease
  • 56 Caring for someone
  • 316 Tributes
  • 122 Discussion forum resources